Q1 2025 Zymeworks Inc Earnings Call Transcript

May 8, 2025 / 08:30 PM GMT

Release Date Price: €9.55 (+0.53%)

Transcript 10-Q8-K

Key Points

Positve

Zymeworks Inc (ZYME) reported a significant increase in revenue for Q1 2025, reaching $27.1 million compared to $10 million in the same period in 2024.
The company achieved a decrease in net loss from $31.7 million in Q1 2024 to $22.6 million in Q1 2025, primarily due to increased revenue.
Zymeworks Inc (ZYME) has a strong cash position with $321.6 million in cash resources, expected to fund operations into the second half of 2027.
The company presented six posters at the AACR annual meeting, showcasing progress in their antibody drug conjugate and T-cell engager pipeline.
Zymeworks Inc (ZYME) is eligible for significant milestone payments and royalties from partnerships, including up to $86 million in development milestones and $373 million in commercial milestone payments from J&J.

Negative

Operating expenses increased by 10% to $52.7 million in Q1 2025 compared to $47.3 million in Q1 2024.
Research and development expenses rose to $35.7 million in Q1 2025 from $32 million in Q1 2024, driven by increased preclinical research expenses.
General and administrative expenses increased to $17 million in Q1 2025 from $15.8 million in Q1 2024, primarily due to higher stock-based compensation.
The company faces uncertainties related to the approval of Zanadatimab for HER2+ biliary tract cancer, which could impact future royalty revenues.
Zymeworks Inc (ZYME) has not provided specific guidance on the timing of data releases for key clinical programs, which may concern investors seeking near-term updates.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ZYME.OQ - Zymeworks Inc
Q1 2025 Zymeworks Inc Earnings Call
May 08, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. This is the conference operator. Welcome to Design Works first quarter 2025 results conference call and webcast. As a reminder, all participants are in listen-only mode and the conference is being recorded.

After the presentation, there'll be an opportunity to ask questions.

To ask a question, press star, then 11 on your telephone keypad.

All night to turn the conference over to Sal and Adar, senior director of investor relations. Sal, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, sir, and good afternoon,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.